Table 4.
Clinical and transplantation characteristics of the MDS-AML patients undergoing MSD-PBSCT
| PCT Group (N/%) | Non-PCT Group (N/%) | X2 value | P value | ||
|---|---|---|---|---|---|
| Age | < 40 years | 12 (50.0%) | 1 (20.0%) | 1.506 | 0.220 |
| ≥ 40 years | 12 (50.0%) | 4 (80.0%) | |||
| Sex | Male | 12 (50.0%) | 4 (80.0%) | 1.506 | 0.220 |
| Female | 12 (50.0%) | 1 (20.0%) | |||
| HCT-CI | < 2 scores | 16 (66.7%) | 1 (20.0%) | 3.715 | 0.054 |
| ≥ 2 scores | 8 (33.3%) | 4 (80.0%) | |||
| Karyotype | Good | 17 (70.8%) | 1 (20.0%) | 7.196 | 0.027 |
| Intermediate | 6 (25.0%) | 2 (40.0%) | |||
| Poor/Very Poor | 1 (4.2%) | 2 (40.0%) | |||
| Age of donor | < 40 years | 13 (54.2%) | 1 (20.0%) | 1.934 | 0.164 |
| ≥ 40 years | 11 (45.8%) | 4 (80.0%) | |||
| Match sex donor-recipient | Male-Male | 8 (33.3%) | 1 (20.0%) | 4.624 | 0.202 |
| Female-Female | 5 (20.8%) | 0 (0%) | |||
| Male-Female | 7 (29.2%) | 1 (20.0%) | |||
| Female-Male | 4 (16.7%) | 3 (60.0%) |